Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-02-25
1995-11-21
Jordan, Kimberly R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514170, A61K 3156
Patent
active
054687365
ABSTRACT:
A method of hormone replacement therapy involves the administration of estrogen together with an amount of antiprogestin which inhibits estrogen-induced endometrial proliferation in a woman.
REFERENCES:
patent: 3890356 (1975-06-01), Grunwell et al.
patent: 3928398 (1975-12-01), Grunwell et al.
patent: 4416822 (1983-11-01), Campbell
patent: 4670426 (1987-06-01), Zor et al.
CA 111(15): 127206n, Van Uern et al., 1989.
Conn's Current Therapy, Menopause, Wulf H, Utian, pp. 1017-1020, 1992.
Barbieri et al., A Clinician's Dilemma, HRT and Breast Cancer Risk, Menopause Management, Jul./Aug. 1992, 12-24.
J. F. H. M. van Uem,, M.D., Contraceptive Potential of RU 486 by Ovulation Inhibition: I. Pituitary Versus Ovarian Action with Blockade of Estrogen-Induced Endometrial Proliferation, Aug. 1989, vol. 40, No. 2, pp. 171-184.
K. A. Steingold, M.D. et al., Antiprogestins in Reproductive Medicine, Sex Steroids, vol. 3, No. 1, Jan. 1992, pp. 233-249.
G. D. Hodgen, PhD., Progesterone Antagonists: Useful for Contraception?, Contemporary OB/GYN Special Issue, pp. 65 and 66, (1988).
Sheth et al., A Randomized, Double-Blind Study of Two Combined and Two Progestogen-Only Oral Contraceptives, Contraception, 25:243, 1982.
Collins et al., Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486, J Clin Endocrinol Metab. 63:1270, 1986.
Danforth et al., Contraceptive Potential of RU 486 By Ovulation Inhibition III Preliminary Observations on Once Weekly Oral Administration, Contraception, 40:195, 1989.
Shoupe et al., Effects of an antiprogenterone RU 486 in normal women II: administration in the late follicular phase, Am J Obstet Gnyecol, 157:1421, 1987.
Liu et al., Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone Ru 486, J Clin Endocrinol Metab, 65:1135, 1987.
Luukkainen et al., Inhibition of folliculogenesis and ovulation by the antigesterone RU 486, Fert Steril, 49:961, 1988.
Batista et al., delayed endometrial matuaration induced by daily administration of antiprogestin RU 486: A patential new contraceptive strategy, Am J Obstet Gynecol, 167:60, 1992.
Messinis et al., The Effect of the Antiprogestin Mifepristone RU-486 On Maturion and In-Vitro Fertilization of Human Ooxytes, Br J Obstet Gynecol, 95(6), 1988-Abstract.
Juneja et al., In Vitro Effect of RU 486 On Sperm-Egg Interaction in Mice, Am J Obstet Gynecol, 163:216, 1990.
Chwalisz et al., Inhibition of Estradiol-Mediated Endometrial Gland Formation by the Antigestagen Onapristone In Rabbits: Relationship to Uterine Estrogen Receptors, Endocrinology 129:312, 1991-Abstract.
Anon., Research Disclosure 28976, 1992.
Hodgen, Surrogate Embryo Transfer Combined with Estrogen-Progesterone Therapy In Monkeys, JAMA 250:2167, 1983.
Chillik et al., Characterizing Pituitary Response to Gonadotropin-releasing Hormone (GnRH) Antagonist in Monkeys: Tonic Follicle-stimulating Hormone/luteinizing Hormone Secretion Versus Acute GnRH Challenge Tests Before, During and After Treatment, Fert. Sterol, 48:480, 1987.
Yoshimura et al., Progesterone Protects Oocytes from Premature Degeneration within the Follicle, Nippon Sanka Fujinka Gakkai Zasshi, 42(9):1256, 1990-Abstract.
Sakiz et al. R 2323-An Original Contraceptive Compound, Excerpta Medica, Abs. 86, 1970.
Spitz, Clinical Applications of the Antiprogestin RU 486, The Endocrinologist, 3:58, 1993.
Gravanis et al., Endometrial and Pituitary Responses to the Steroidal Antiprogestin RU 486 in Postmenopausal Women, J. Endocrinol. Metab. 60:156, 1986.
Wolf et al., Noncompetitive Antiestrogenic Effect of RU 486 in Blocking the Estrogen Stimulated Luteinizing Hormone Surge and the Proliferative Action of Estradiol on Endometrium in Castrate Monkeys, Fert. Steril., 52:1055, 1989.
Jordan Kimberly R.
The Medical College of Hampton Road
LandOfFree
Hormone replacement therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hormone replacement therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hormone replacement therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137219